MXXVX
Price
$36.87
Change
-$0.81 (-2.15%)
Updated
Aug 1 closing price
Net Assets
318.73M
VTSAX
Price
$148.89
Change
-$2.49 (-1.64%)
Updated
Aug 1 closing price
Net Assets
1.91T
Interact to see
Advertisement

MXXVX vs VTSAX

Header iconMXXVX vs VTSAX Comparison
Open Charts MXXVX vs VTSAXBanner chart's image
Matthew 25
Price$36.87
Change-$0.81 (-2.15%)
VolumeN/A
Net Assets318.73M
Vanguard Total Stock Mkt Idx Adm
Price$148.89
Change-$2.49 (-1.64%)
VolumeN/A
Net Assets1.91T
MXXVX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MXXVX vs. VTSAX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXXVX is a Hold and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. MXXVX (319M). VTSAX pays higher dividends than MXXVX: VTSAX (1.18) vs MXXVX (0.00). MXXVX was incepted earlier than VTSAX: MXXVX (30 years) vs VTSAX (25 years). MXXVX (1.10) is less costly to investors than VTSAX (0.04). MXXVX is a more actively managed with annual turnover of: 30.26 vs. VTSAX (2.00). VTSAX has a lower initial minimum investment than MXXVX: VTSAX (3000) vs MXXVX (10000). MXXVX annual gain was more profitable for investors over the last year : 17.90 vs. VTSAX (15.97). VTSAX return over 5 years is better than : 88.61 vs. MXXVX (28.36).
MXXVXVTSAXMXXVX / VTSAX
Total Expense Ratio1.100.042,750%
Annual Report Gross Expense Ratio1.100.042,750%
Fund Existence30 years25 years-
Gain YTD9.0287.388122%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets319M1.91T0%
Annual Yield % from dividends0.001.18-
Returns for 1 year17.9015.97112%
Returns for 3 years30.0252.4157%
Returns for 5 years28.3688.6132%
Returns for 10 years27.18198.7314%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT27.070.70
+2.65%
Summit Therapeutics
TK7.230.03
+0.42%
Teekay Corporation Ltd
LIVN41.13-1.06
-2.51%
LivaNova PLC
XHLD0.33-0.02
-4.78%
TEN Holdings Inc
LTRX2.94-0.27
-8.41%
Lantronix